| 货号 |
中文名称 |
英文名词 |
靶点 |
|
VAPD00081 |
Research Grade Romosozumab ( 洛莫索珠单抗 ) Biosimilar
|
|
SOST, Sclerostin |
|
VAPD00080 |
Research Grade Rituximab ( 利妥昔单抗 ) Biosimilar
|
|
CD20, B-lymphocyte antigen CD20，MS4A1 |
|
VAPD00079 |
Research Grade Reslizumab ( 瑞利珠单抗 ) Biosimilar
|
|
IL5, Interleukin-5 |
|
VAPD00078 |
Research Grade Ramucirumab ( 雷莫芦单抗 ) Biosimilar
|
|
KDR, FLK1, VEGFR2 |
|
VAPD00077 |
Research Grade Polatuzumab( 波拉珠单抗) Biosimilar
|
|
CD79b, B29, IGB |
|
VAPD00076 |
Research Grade Pertuzumab ( 珀妥珠单抗 ) Biosimilar
|
|
HER2，ERBB2 |
|
VAPD00075 |
Research Grade Pembrolizumab ( 兰洛利珠单抗 ) Biosimilar
|
|
PD1, CD279, PDCD1 |
|
VAPD00074 |
Research Grade Palivizumab ( 帕利珠单抗 ) Biosimilar
|
|
Fusion glycoprotein F0, Protein F |
|
VAPD00073 |
Research Grade Otilimab ( 奥替利单抗 ) Biosimilar
|
|
CSF2, GM-CSF |
|
VAPD00072 |
Research Grade Otelixizumab ( 奥昔组单抗 ) Biosimilar
|
|
CD3 |
